ANA GUERRA: Open Payments
NPI 1679280952 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,488 in 54 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $30 · 2025 $1,488
Food & beverage: $1,488
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $343 |
| Corcept Therapeutics | 8 | $270 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $149 |
| Abbott Laboratories | 2 | $140 |
| Amgen Inc. | 9 | $136 |
| Janssen Biotech, Inc. | 1 | $105 |
| Lilly USA, LLC | 3 | $51 |
| Novo Nordisk Inc | 3 | $46 |
| Astellas Pharma US Inc | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
Products named: Korlym, Kerendia, FREESTYLE LIBRE 3, BREZTRI, FARXIGA, TREMFYA, AIRSUPRA, REPATHA.
Industry payments across TX — which companies pay providers there.
